Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G9WP
|
||||
Former ID |
DNC009637
|
||||
Drug Name |
5-Pyridin-3-yl-2,3-dihydro-1H-inden-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529834] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H11NO
|
||||
Canonical SMILES |
C1CC(=O)C2=C1C=C(C=C2)C3=CN=CC=C3
|
||||
InChI |
1S/C14H11NO/c16-14-6-4-11-8-10(3-5-13(11)14)12-2-1-7-15-9-12/h1-3,5,7-9H,4,6H2
|
||||
InChIKey |
QNSOPUXDEXJMIY-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [529834] | |
Cytochrome P450 19 | Target Info | Inhibitor | [529834] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | SteroidogenesisPW000045:Androgen and Estrogen Metabolism | ||||
WikiPathways | Metapathway biotransformation | ||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Corticotropin-releasing hormoneWP702:Metapathway biotransformation | |||||
Tryptophan metabolism | |||||
Ovarian Infertility Genes | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compounds | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.